Christina Y. Chen

Christina Y. Chen

Auto-generated profile, based on publicly available information

Christina Y. Chen

Division of Community Internal Medicine, Geriatrics and Palliative Care, Mayo Clinic, Rochester, MN; Division of Geriatrics and Gerontology, Mayo Clinic, Rochester, MN; Department of General Internal Medicine, Mayo Clinic, Rochester, MN

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Open access
PDF file
LWLauren M. Webb
Lauren M. Webb
CCChristina Y. Chen
Christina Y. Chen
Key points: Rates of anxiety and depression have increased during the COVID‐19 pandemic in older adults. Younger generations have reported higher rates of anxiety and depression during the pandemic compared to older adults. Factors influencing the risk of mental illness in older adults during the pandemic include sex, age group, location, living situation, socioeconomic status, and medical and psychiatric comorbidities. Strategies for older adults, caregivers, and health‐care providers may mitigate the effects of social isolation on the older adult population.

1 January 2015 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
CCChristina Y. Chen
Christina Y. Chen
BTBjorg Thorsteinsdottir
Bjorg Thorsteinsdottir
SCStephen S. Cha
Stephen S. Cha
GHGregory J. Hanson
Gregory J. Hanson
SPStephanie M. Peterson
Stephanie M. Peterson
PTPaul Y. Takahashi
Paul Y. Takahashi
Approximately 20% of seniors live with five or more chronic medical illnesses. Terminal stages of their lives are often characterized by repeated burdensome hospitalizations and advance care directives are insufficiently addressed. This study reports on the preliminary results of a Palliative Care Homebound Program (PCHP) at the Mayo Clinic in Rochester, Minnesota to service these vulnerable populations. The study objective was to evaluate inpatient hospital utilization and the adequacy of advance care planning in patients who receive home-based palliative care. This is a retrospective pilot cohort study of patients enrolled in the PCHP between September 2012 and March 2013. Two control patients were matched to each intervention patient by propensity scoring methods that factor in risk and prognosis. Primary outcomes were six-month hospital utilization including ER visits. Secondary outcomes evaluated advance care directive completion and overall mortality. Patients enrolled in the PCHP group (n = 54) were matched to 108 controls with an average age of 87 years. Ninety-two percent of controls and 33% of PCHP patients were admitted to the hospital at least once. The average number of hospital admissions was 1.36 per patient for controls versus 0.35 in the PCHP (p < 0.001). Total hospital days were reduced by 5.13 days. There was no difference between rates of ER visits. Advanced care directive were completed more often in the intervention group (98%) as compared to controls (31%), with p < 0.001. Goals of care discussions were held at least once for all patients in the PCHP group, compared to 41% in the controls.

11 October 2024 in Circulation Research
Verified
Journal Article
Open access
NPNiels Pietsch
Niels Pietsch
CCChristina Y. Chen
Christina Y. Chen
SKSvenja Kupsch
Svenja Kupsch
LBLucas Bacmeister
Lucas Bacmeister
BGBirgit Geertz
Birgit Geertz
LCLucie Carrier
Lucie Carrier
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is the most common cardiac genetic disorder caused by sarcomeric gene variants and associated with left ventricular hypertrophy and diastolic dysfunction. The role of the microtubule network has recently gained interest with the findings that microtubule detyrosination (dTyr-MT) is markedly elevated in heart failure. Acute reduction of dTyr-MT by inhibition of the detyrosinase (VASH [vasohibin]/SVBP [small VASH-binding protein] complex) or activation of the tyrosinase (TTL [tubulin tyrosine ligase]) markedly improved contractility and reduced stiffness in human failing cardiomyocytes and thus posed a new perspective for HCM treatment. In this study, we tested the impact of chronic tubulin tyrosination in an HCM mouse model ( Mybpc3 knock-in), in human HCM cardiomyocytes, and in SVBP-deficient human engineered heart tissues (EHTs). METHODS: Adeno-associated virus serotype 9–mediated TTL transfer was applied in neonatal wild-type rodents, in 3-week-old knock-in mice, and in HCM human induced pluripotent stem cell–derived cardiomyocytes. RESULTS: We show (1) TTL for 6 weeks dose dependently reduced dTyr-MT and improved contractility without affecting cytosolic calcium transients in wild-type cardiomyocytes; (2) TTL for 12 weeks reduced the abundance of dTyr-MT in the myocardium, improved diastolic filling, compliance, cardiac output, and stroke volume in knock-in mice; (3) TTL for 10 days normalized cell area in HCM human induced pluripotent stem cell–derived cardiomyocytes; (4) TTL overexpression activated transcription of tubulins and other cytoskeleton components but did not significantly impact the proteome in knock-in mice; (5) SVBP-deficient EHTs exhibited reduced dTyr-MT levels, higher force, and faster relaxation than TTL-deficient and wild-type EHTs. RNA sequencing and mass spectrometry analysis revealed distinct enrichment of cardiomyocyte components and pathways in SVBP-deficient versus TTL-deficient EHTs. CONCLUSIONS: This study provides the first proof of concept that chronic activation of tubulin tyrosination in HCM mice and in human EHTs improves heart function and holds promise for targeting the nonsarcomeric cytoskeleton in heart disease.

1 December 2018 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
CCChristina Y. Chen
Christina Y. Chen
JNJames M. Naessens
James M. Naessens
PTPaul Y. Takahashi
Paul Y. Takahashi
RMRozalina G. McCoy
Rozalina G. McCoy
BBBijan J. Borah
Bijan J. Borah
GHGregory J. Hanson
Gregory J. Hanson

1 November 2017 in The Journal for Nurse Practitioners
Verified
Journal Article
Closed access
PDF file
JSJoshua S. Shapiro
Joshua S. Shapiro
RMRozalina G. McCoy
Rozalina G. McCoy
PTPaul Y. Takahashi
Paul Y. Takahashi
BTBjorg Thorsteinsdottir
Bjorg Thorsteinsdottir
SPStephanie M. Peterson
Stephanie M. Peterson
LBLynn S. Borkenhagen
Lynn S. Borkenhagen

1 March 2020 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
PDF file
CCChristina Y. Chen
Christina Y. Chen
BVBrandon Verdoorn
Brandon Verdoorn